Market revenue in 2023 | USD 2,578.1 million |
Market revenue in 2030 | USD 3,974.7 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III |
Phase iii was the largest segment with a revenue share of 52.75% in 2023. Horizon Databook has segmented the Global clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
The geographical distribution base of clinical trials is shifting from developed nations to emerging countries. The rising cost of clinical trials and difficulty in patient recruitment has led biopharmaceutical companies to shift towards regions such as Central and Eastern Europe, Asia pacific, Latin America and Middle East for cost efficiency and quick patient recruitment.
Emerging countries also possess greater disease variation compared to the west, where traditional diseases are growing. The greater disease variation among the developing countries helps biopharmaceutical companies to perform clinical trials on rare diseases.
Regions such as Asia Pacific also provides greater economic benefits to biopharmaceutical companies as governments in Singapore and China allocate funds to promote biomedical research in the region. Latin America, where population speak only Portuguese and Spanish, also reduces barriers to informed consent which helps in easy patient recruitment and faster clinical trials.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Phase | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 1,187.2 | 1,271.8 | 1,360.2 | 1,337.1 | 1,353.9 | 1,430.5 | 1,513.0 | 1,601.7 | 1,697.3 | 1,800.5 | 1,911.7 | 2,051.8 | 2,206.3 | 6.4% |
Europe | 510.1 | 545.5 | 585.8 | 587.3 | 593.4 | 626.8 | 663.6 | 704.6 | 750.0 | 800.4 | 856.5 | 901.1 | 949.7 | 6.1% |
Asia Pacific | 359.5 | 382.5 | 407.8 | 408.5 | 413.9 | 438.3 | 465.4 | 495.6 | 529.2 | 566.8 | 608.5 | 654.1 | 704.4 | 7.0% |
Latin America | 39.3 | 41.9 | 44.7 | 45.2 | 45.5 | 47.7 | 50.1 | 52.7 | 55.5 | 58.5 | 61.6 | 64.5 | 67.6 | 5.1% |
MEA | 29.2 | 31.2 | 33.4 | 33.3 | 33.4 | 34.8 | 36.5 | 38.2 | 40.1 | 42.1 | 44.2 | 46.0 | 46.7 | 4.3% |
Overall | 2,125.3 | 2,272.9 | 2,431.9 | 2,411.4 | 2,440.1 | 2,578.1 | 2,728.6 | 2,892.8 | 3,072.1 | 3,268.3 | 3,482.5 | 3,717.5 | 3,974.7 | 6.4% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account